Tag: losartan market analysis

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Losartan Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The market for losartan has experienced consistent expansion, projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 4.2%. This growth trajectory in the historical period is largely attributable to the escalating global prevalence of hypertension, the broad clinical acceptance of angiotensin II receptor blockers (ARBs), a rise in diabetes-induced kidney illnesses, heightened public consciousness regarding cardiovascular risk mitigation, and a discernible shift from ACE inhibitors to ARBs for treatment.

The global losartan market is projected to experience consistent expansion, reaching an estimated value of $1.83 billion by 2030 with a compound annual growth rate of 4.3%. This anticipated growth trajectory is fueled by several key factors, including an increasing elderly demographic, a heightened demand for antihypertensive medications that safeguard kidney function, broadened availability of cost-effective generic versions, a greater emphasis on preventing strokes, and increased healthcare expenditures dedicated to managing chronic conditions. Within this forecast period, significant market dynamics are expected to include a rise in hypertension and cardiovascular ailments, a discernible shift favoring angiotensin II receptor blockers (ARBs) over angiotensin-converting enzyme (ACE) inhibitors, a surge in prescriptions for generic losartan, its growing application in managing diabetic nephropathy, and a greater adoption of long-term blood pressure management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Losartan Market Industry Drivers: What Is Driving Revenue Growth?

The increasing frequency of hypertension is anticipated to drive the expansion of the losartan market in the future, as this condition, characterized by consistently elevated blood pressure, significantly heightens the risk of cardiovascular ailments, cerebrovascular incidents, and other grave health issues, with its rising occurrence often associated with diets high in sodium and processed items that promote fluid retention and cardiac stress, and losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for blood vessel constriction, thereby facilitating vessel relaxation and dilation, consequently reducing blood pressure and alleviating the heart’s exertion; for example, data from the Centers for Disease Control and Prevention indicated that in 2023, hypertension was a direct or contributing factor in 664,470 fatalities within the United States, underscoring the direct correlation between the escalating prevalence of hypertension and the burgeoning losartan market.

Losartan Market Segmentation Trends And Revenue Drivers

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

#Losartan Market Growth Trends: What Is Influencing The Future Outlook?

To address patient needs and broaden treatment possibilities within the losartan market, leading manufacturers are prioritizing the creation of novel products and securing necessary authorizations, exemplified by the introduction of losartan potassium oral suspension. This liquid rendition of losartan potassium is designed specifically for those who find swallowing pills challenging. A case in point is Scienture Holdings Inc., a pharmaceutical enterprise based in the United States, which obtained approval from the Food and Drug Administration (FDA) in March 2025 for Arbli. This pre-prepared liquid treatment targets hypertension, aims to decrease stroke risk in hypertensive individuals experiencing left ventricular hypertrophy, and addresses diabetic nephropathy in patients with type 2 diabetes, providing accurate dosages without the need for specialized preparation and maintaining an eighteen-month stability at ambient temperatures in a 165 mL peppermint-flavored suspension containing 10 mg/mL.

Losartan Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Losartan Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the losartan market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Losartan Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The market for losartan has experienced consistent expansion, projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 4.2%. This growth trajectory in the historical period is largely attributable to the escalating global prevalence of hypertension, the broad clinical acceptance of angiotensin II receptor blockers (ARBs), a rise in diabetes-induced kidney illnesses, heightened public consciousness regarding cardiovascular risk mitigation, and a discernible shift from ACE inhibitors to ARBs for treatment.

The global losartan market is projected to experience consistent expansion, reaching an estimated value of $1.83 billion by 2030 with a compound annual growth rate of 4.3%. This anticipated growth trajectory is fueled by several key factors, including an increasing elderly demographic, a heightened demand for antihypertensive medications that safeguard kidney function, broadened availability of cost-effective generic versions, a greater emphasis on preventing strokes, and increased healthcare expenditures dedicated to managing chronic conditions. Within this forecast period, significant market dynamics are expected to include a rise in hypertension and cardiovascular ailments, a discernible shift favoring angiotensin II receptor blockers (ARBs) over angiotensin-converting enzyme (ACE) inhibitors, a surge in prescriptions for generic losartan, its growing application in managing diabetic nephropathy, and a greater adoption of long-term blood pressure management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Losartan Market Industry Drivers: What Is Driving Revenue Growth?

The increasing frequency of hypertension is anticipated to drive the expansion of the losartan market in the future, as this condition, characterized by consistently elevated blood pressure, significantly heightens the risk of cardiovascular ailments, cerebrovascular incidents, and other grave health issues, with its rising occurrence often associated with diets high in sodium and processed items that promote fluid retention and cardiac stress, and losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for blood vessel constriction, thereby facilitating vessel relaxation and dilation, consequently reducing blood pressure and alleviating the heart’s exertion; for example, data from the Centers for Disease Control and Prevention indicated that in 2023, hypertension was a direct or contributing factor in 664,470 fatalities within the United States, underscoring the direct correlation between the escalating prevalence of hypertension and the burgeoning losartan market.

Losartan Market Segmentation Trends And Revenue Drivers

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

#Losartan Market Growth Trends: What Is Influencing The Future Outlook?

To address patient needs and broaden treatment possibilities within the losartan market, leading manufacturers are prioritizing the creation of novel products and securing necessary authorizations, exemplified by the introduction of losartan potassium oral suspension. This liquid rendition of losartan potassium is designed specifically for those who find swallowing pills challenging. A case in point is Scienture Holdings Inc., a pharmaceutical enterprise based in the United States, which obtained approval from the Food and Drug Administration (FDA) in March 2025 for Arbli. This pre-prepared liquid treatment targets hypertension, aims to decrease stroke risk in hypertensive individuals experiencing left ventricular hypertrophy, and addresses diabetic nephropathy in patients with type 2 diabetes, providing accurate dosages without the need for specialized preparation and maintaining an eighteen-month stability at ambient temperatures in a 165 mL peppermint-flavored suspension containing 10 mg/mL.

Losartan Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Losartan Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the losartan market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Losartan Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The market for losartan has experienced consistent expansion, projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 4.2%. This growth trajectory in the historical period is largely attributable to the escalating global prevalence of hypertension, the broad clinical acceptance of angiotensin II receptor blockers (ARBs), a rise in diabetes-induced kidney illnesses, heightened public consciousness regarding cardiovascular risk mitigation, and a discernible shift from ACE inhibitors to ARBs for treatment.

The global losartan market is projected to experience consistent expansion, reaching an estimated value of $1.83 billion by 2030 with a compound annual growth rate of 4.3%. This anticipated growth trajectory is fueled by several key factors, including an increasing elderly demographic, a heightened demand for antihypertensive medications that safeguard kidney function, broadened availability of cost-effective generic versions, a greater emphasis on preventing strokes, and increased healthcare expenditures dedicated to managing chronic conditions. Within this forecast period, significant market dynamics are expected to include a rise in hypertension and cardiovascular ailments, a discernible shift favoring angiotensin II receptor blockers (ARBs) over angiotensin-converting enzyme (ACE) inhibitors, a surge in prescriptions for generic losartan, its growing application in managing diabetic nephropathy, and a greater adoption of long-term blood pressure management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Losartan Market Industry Drivers: What Is Driving Revenue Growth?

The increasing frequency of hypertension is anticipated to drive the expansion of the losartan market in the future, as this condition, characterized by consistently elevated blood pressure, significantly heightens the risk of cardiovascular ailments, cerebrovascular incidents, and other grave health issues, with its rising occurrence often associated with diets high in sodium and processed items that promote fluid retention and cardiac stress, and losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for blood vessel constriction, thereby facilitating vessel relaxation and dilation, consequently reducing blood pressure and alleviating the heart’s exertion; for example, data from the Centers for Disease Control and Prevention indicated that in 2023, hypertension was a direct or contributing factor in 664,470 fatalities within the United States, underscoring the direct correlation between the escalating prevalence of hypertension and the burgeoning losartan market.

Losartan Market Segmentation Trends And Revenue Drivers

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

#Losartan Market Growth Trends: What Is Influencing The Future Outlook?

To address patient needs and broaden treatment possibilities within the losartan market, leading manufacturers are prioritizing the creation of novel products and securing necessary authorizations, exemplified by the introduction of losartan potassium oral suspension. This liquid rendition of losartan potassium is designed specifically for those who find swallowing pills challenging. A case in point is Scienture Holdings Inc., a pharmaceutical enterprise based in the United States, which obtained approval from the Food and Drug Administration (FDA) in March 2025 for Arbli. This pre-prepared liquid treatment targets hypertension, aims to decrease stroke risk in hypertensive individuals experiencing left ventricular hypertrophy, and addresses diabetic nephropathy in patients with type 2 diabetes, providing accurate dosages without the need for specialized preparation and maintaining an eighteen-month stability at ambient temperatures in a 165 mL peppermint-flavored suspension containing 10 mg/mL.

Losartan Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Losartan Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the losartan market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Expansion Is Expected For The Losartan Market Over The Forecast Period?

The losartan market has experienced steady expansion in recent years. Its value is projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, at a compound annual growth rate (CAGR) of 4.2%. Historically, this development can be linked to factors such as the escalating global burden of hypertension, the widespread clinical acceptance of ARBs, the increasing incidence of diabetes-related kidney disease, enhanced awareness of cardiovascular risk management, and an early transition from ACE inhibitors to ARBs.

The market size for losartan is anticipated to show consistent expansion over the upcoming years. Its valuation is projected to reach $1.83 billion by 2030, achieving a compound annual growth rate (CAGR) of 4.3%. The projected growth within this period stems from drivers such as an expanding aging demographic, an increasing requirement for kidney-protective antihypertensive medications, broader availability of inexpensive generic versions, a heightened emphasis on stroke prevention, and greater healthcare expenditure dedicated to managing chronic diseases. Significant trends expected during the forecast timeframe include the rising occurrence of hypertension and cardiovascular conditions, a developing inclination towards ARBs rather than ACE inhibitors, a wider distribution of generic losartan prescriptions, its growing application in the management of diabetic nephropathy, and an increase in the adoption of long-term blood pressure control therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Significant Factors Are Encouraging Growth In The Losartan Market?

The increasing occurrence of hypertension is anticipated to propel the expansion of the losartan market in the future. Hypertension, characterized by consistently elevated blood pressure, significantly increases the risk of heart disease, stroke, and various other serious health issues. This rising incidence of hypertension is often linked to diets high in salt and processed items, contributing to fluid retention and putting extra stress on the heart. Losartan aids in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action promotes relaxation and widening of the vessels, thereby reducing blood pressure and alleviating the heart’s effort. For example, in January 2025, according to the Centers for Disease Control and Prevention, a US-based organisation, in 2023, high blood pressure played a primary or contributing role in 664,470 deaths in the United States. Consequently, the expanding prevalence of hypertension is a key factor driving the growth of the losartan market.

What Segment Categories Are Evaluated In The Losartan Market Study?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Trends Are Influencing The Losartan Market Outlook?

Major companies operating in the losartan market are emphasizing the development of innovative products and securing approvals, such as losartan potassium oral suspension, to enhance patient compliance and broaden therapeutic applications. Losartan potassium oral suspension is a liquid form of the medication losartan potassium, intended for individuals who experience difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. This is a ready-to-use liquid formulation designed for hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. It provides precise dosing without compounding and is supplied as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Key Market Participants In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Region Has The Strongest Presence In The Losartan Market?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Losartan Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Losartan Market In 2026 And 2030?

The losartan market size has demonstrated consistent expansion in recent years. It is anticipated to increase from $1.49 billion in 2025 to $1.55 billion in 2026, progressing at a compound annual growth rate (CAGR) of 4.2%. Historically, this growth was primarily driven by factors such as the escalating global burden of hypertension, the widespread clinical adoption of ARBs, a rising incidence of diabetes-related kidney disease, improved awareness of cardiovascular risk management, and an early shift from ACE inhibitors to ARBs.

The losartan market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach $1.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. Factors driving this expansion during the forecast period include an aging global populace, an increasing need for kidney-protecting antihypertensive medications, broader availability of cost-effective generic drugs, a heightened emphasis on preventing strokes, and greater healthcare expenditure directed towards managing chronic illnesses. Key trends anticipated during the same period encompass the growing incidence of hypertension and cardiovascular conditions, a developing preference for ARBs over ACE inhibitors, an increase in prescriptions for generic losartan, its expanding application in the management of diabetic nephropathy, and a surge in the adoption of long-term blood pressure control therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Key Factors Are Driving The Losartan Market Growth?

The increasing prevalence of hypertension is expected to propel the growth of the losartan market going forward. Hypertension is a condition characterized by persistently elevated blood pressure, which can increase the likelihood of heart disease, stroke, and other severe health complications. The rising incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased strain on the heart. Losartan helps control hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This action aids in relaxing and widening the vessels, consequently lowering blood pressure and easing the heart’s workload. For instance, in January 2025, according to the Centers for Disease Control and Prevention, a US-based organisation, in 2023, high blood pressure played a primary or contributing role in 664,470 deaths in the United States. Therefore, the growing prevalence of hypertension is driving the growth of the losartan market.

How Are Segments Identified Within The Losartan Market Segment Framework?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

Which Trends Are Guiding The Direction Of The Losartan Market?

Major companies operating in the losartan market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to improve patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of medication losartan potassium, intended for individuals who experience difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) clearance for Arbli. It is a ready-to-use liquid formulation designed for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without compounding and is available as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Companies Competing Within The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Get The Full Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Region Leads The Losartan Market In Overall Market Size?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Losartan Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Market Report 2026

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Market Report

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Market Report

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Losartan Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The losartan market size has shown consistent growth in recent years. Its value is anticipated to rise from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.2%. This past growth can be attributed to several factors including an increasing global prevalence of hypertension, the widespread clinical adoption of ARBs, a rising incidence of kidney disease linked to diabetes, improved public awareness concerning cardiovascular risk management, and an early transition from ACE inhibitors to ARBs.

The losartan market size is anticipated to demonstrate sustained expansion in the upcoming years, projected to reach $1.83 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.3%. This expected growth during the forecast period is largely influenced by an aging global demographic, a surging demand for medications that protect kidneys and reduce blood pressure, enhanced access to affordable generic versions, an increased focus on preventing strokes, and elevated healthcare spending directed towards the treatment of chronic conditions. Key trends identified for the forecast period encompass a rising prevalence of hypertension and various cardiovascular ailments, an escalating preference for ARBs over ACE inhibitors, a wider distribution of generic losartan prescriptions, its growing application in the management of diabetic nephropathy, and an increased embrace of long-term therapies for blood pressure control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Losartan Market?

The increasing incidence of hypertension is projected to boost the expansion of the losartan market in the coming years. Hypertension is defined as a state characterized by sustained elevated blood pressure, which significantly elevates the risk of cardiac ailments, strokes, and various other serious health issues. The rising occurrence of hypertension is often associated with diets high in salt and processed foods, leading to fluid accumulation and increased strain on the heart. Losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for constricting blood vessels. This action facilitates the relaxation and widening of these vessels, thereby reducing blood pressure and lessening the heart’s burden. As an illustration, in January 2025, the Centers for Disease Control and Prevention, a US-based organisation, reported that in 2023, high blood pressure was a primary or contributing factor in 664,470 deaths within the United States. Consequently, the escalating prevalence of hypertension is fueling the growth of the losartan market.

What Major Segment Divisions Exist Within The Losartan Market?

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

What Trends Are Projected To Affect The Losartan Market?

Leading companies in the losartan market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to improve patient adherence and expand its therapeutic applications. Losartan potassium oral suspension is a liquid version of the losartan potassium medication, specifically formulated for individuals who find swallowing tablets challenging. For example, in March 2025, Scienture Holdings Inc., a biopharmaceutical company based in the US, was granted Food and Drug Administration (FDA) approval for Arbli. This product is a ready-to-use liquid formulation designed for hypertension, for reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and for diabetic nephropathy in type 2 diabetes patients. It allows for precise dosing without compounding and is provided as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life when stored at room temperature.

Which Companies Are Leading Innovation In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Read the full losartan market report here:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

What Are The Leading Geographic Regions In The Losartan Market?

North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Losartan Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2026, By The Business Research Company

Lysine Global Market Report

https://www.thebusinessresearchcompany.com/report/lysine-global-market-report

Caviar Global Market Report

https://www.thebusinessresearchcompany.com/report/caviar-global-market-report

Liraglutide Global Market Report

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model